Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  Probi AB (publ)    PROB   SE0001280355

PROBI AB (PUBL)

(PROB)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Stockholm
01/18/2021 01/19/2021 01/20/2021 01/21/2021 01/22/2021 Date
471(c) 471.5(c) 473.5(c) 482(c) 483(c) Last
3 354 1 960 2 792 3 400 3 383 Volume
+0.64% +0.11% +0.42% +1.80% +0.21% Change
More quotes
Financials
Sales 2020 711 M 85,8 M 85,8 M
Net income 2020 102 M 12,2 M 12,2 M
Net cash position 2020 259 M 31,3 M 31,3 M
P/E ratio 2020 54,3x
Yield 2020 0,32%
Sales 2021 758 M 91,4 M 91,4 M
Net income 2021 117 M 14,1 M 14,1 M
Net cash position 2021 360 M 43,4 M 43,4 M
P/E ratio 2021 46,7x
Yield 2021 0,45%
Capitalization 5 503 M 664 M 664 M
EV / Sales 2020 7,38x
EV / Sales 2021 6,79x
Nbr of Employees -
Free-Float 39,3%
More Financials
Company
Probi AB is a Sweden-based company engaged in the probiotics research and development. The Company’s activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi probiotics in collaboration with a range of entities, such as pharmaceutical companies... 
Sector
Food Processing
Calendar
02/09Earnings Release
More about the company
Notations Surperformance© of Probi AB (publ)
Trading Rating : Investor Rating :
More Ratings
All news about PROBI AB (PUBL)
01/15PROBI : Truths, Facts and Why Probiotics Matter (IPA webinar for media)
AQ
2020Q3 2020 : Strong growth with good profitability
AQ
2020PROBI : acquires shares in Vital Nutrients Holdings and enters into strategic pa..
AQ
2020PROBI : Presentation of Probi's Q3 report
AQ
2020PROBI : New clinical results on stress from Probi and their probiotic strain L. ..
AQ
2020Q2 2020 : Probi raises long-term financial targets
AQ
2020PROBI PUBL : Presentation of Probi's Q2 report 2020 and new financial targets
PU
2020PROBI PUBL : Presentation of Probi's Q2 report 2020 and new financial targets
AQ
2020PROBI PUBL : and Örebro University to collaborate on research into exploration o..
AQ
2020PROBI PUBL : A true pioneer in probiotic research is elected NutraChampion 2020
AQ
2020PROBI AB (PUBL) : Ex-dividend day for final dividend
FA
2020PROBI PUBL : ´s Annual General Meeting 2020
PU
2020PROBI PUBL : Annual General Meeting 2020
AQ
2020Q1 2020 : A solid start to the year
AQ
2020PROBI PUBL : Presentation of Probi's Q1 report 2020
PU
More news
News in other languages on PROBI AB (PUBL)
2020PROBI AB (PUBL) : rentabilité renforcée
2018PROBI AB : Veröffentlichung des Halbjahresergebnisses
2018PROBI AB : publication des résultats semestriels
2018PROBI AB : Veröffentlichung des Jahresergebnisses
2018PROBI AB : publication des résultats annuels
More news
Analyst Recommendations on PROBI AB (PUBL)
More recommendations
Chart PROBI AB (PUBL)
Duration : Period :
Probi AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PROBI AB (PUBL)
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts 2
Average target price 440,00 SEK
Last Close Price 483,00 SEK
Spread / Highest target -8,90%
Spread / Average Target -8,90%
Spread / Lowest Target -8,90%
EPS Revisions
Managers and Directors
NameTitle
Tom Juhani Rönnlund Chief Executive Officer
Jean-Yves Parisot Chairman
Andy McShea Vice President-Operations
Henrik Lundkvist Chief Financial Officer
Niklas Brandt Vice President-Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
PROBI AB (PUBL)14.46%664
BY-HEALTH CO., LTD.7.62%6 340
BALCHEM CORPORATION2.27%3 812
THE SIMPLY GOOD FOODS COMPANY-12.63%2 623
MEDIFAST, INC.12.72%2 588
BIOGAIA AB (PUBL)-5.77%1 233